| Return on average equity - 5 year average | - |
| Net Income/employee - trailing 12 month | 22,37,496.00 |
| Revenue/employee - most recent fiscal year | - |
| Return on investment - most recent fiscal year | 21.39 |
| Return on average assets - most recent fiscal year | 19.17 |
| Receivables turnover - most recent fiscal year | 3.25 |
| Return on investment - trailing 12 month | - |
| Return on average assets - trailing 12 month | - |
| Inventory turnover - most recent fiscal year | 1.56 |
| Inventory turnover - trailing 12 month | - |
| Revenue/employee - trailing 12 month | 73,85,180.00 |
| Return on average assets - 5 year average | - |
| Net Income/employee - most recent fiscal year | - |
| Return on average equity - trailing 12 month | - |
| Receivables turnover - trailing 12 month | - |
| Asset turnover - most recent fiscal year | 0.63 |
| Asset turnover - trailing 12 month | - |
| Return on average equity - most recent fiscal year | 21.88 |
| Return on investment - 5 year average | - |
Concord Biotech Dividend Concord Biotech Bonus Concord Biotech News Concord Biotech AGM Concord Biotech Rights Concord Biotech Splits Concord Biotech Board Meetings Concord Biotech Shareholdings Concord Biotech Profit Loss Concord Biotech Balance Sheet Concord Biotech Cashflow Concord Biotech Q1 Results Concord Biotech Q2 Results Concord Biotech Q3 Results Concord Biotech Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks